Target Audience
Cardiologists, Lipidologists, and other healthcare professionals responsible for the diagnosis, treatment or management of patients with dyslipidemia.
Learning Objectives
- Review advances in LDL-C science and the role of LDL-C in CVD prevention
- Understand the current ACC/AHA/ESC/NLA guidelines for the management of patients with dyslipidemia.
- Analyze extended CVD Outcomes clinical trial data for PCSK9 inhibitor therapeutics.
- Apply newer scientific knowledge and data into personalized treatment plans for patients with statin intolerance, familial hypercholesterolemia, and dyslipidemia patients not at LDL-C goal.
Agenda
| 6:30 – 7:00 pm | Registration and Dinner |
| 7:00 – 7:10 pm | Introduction and State of the Science: Dyslipidemia |
| 7:10 – 7:25 pm | Analyzing the Role of LDL-C in Atherosclerotic Disease and Guidelines Update |
| 7:25 – 7:30 pm | Interactive Expert Panel Discussion |
| 7:30 – 7:50 pm | Screening, Diagnosis and Current Management of Patients with FH |
| 7:50 – 8:00 pm | Interactive Expert Panel Discussion |
| 8:00 – 8:20 pm | CVD Outcomes Data for PCSK9 Inhibitor Therapeutics |
| 8:20 – 8:30 pm | Interactive Expert Panel Discussion |
| 8:30 – 9:00 pm | Lipid Clinic: Grand Rounds |
Location
Philadelphia Downtown Marriott
Grand Ballroom BCD
1201 Market St.
Philadelphia, PA 19107
Registration Fees
This a complimentary CME symposium.
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the National Lipid Association and AcademicCME. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity is eligible for CDR credit.
This activity is endured and distributed through the Elsevier Office of Continuing Medical Education.
CE Inquiries/Special Needs
For all CE inquiries or special needs, please contact: [email protected] or 6106873300.
Financial Support
This activity has been supported by an independent educational grant from Amgen Inc.
Faculty
Christopher P. Cannon, MD
Professor of Medicine
Harvard Medical School
Executive Director of Cardiometabolic Trials
Baim Institute for Clinical Research
Senior Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Christie M. Ballantyne, MD
Professor of Medicine
Baylor College of Medicine
Center for Cardiovascular Disease Prevention
Houston Methodist DeBakey Heart & Vascular Center
Baylor College of Medicine
Houston, Texas
Harold E. Bays, MD
Medical Director and President
Louisville Metabolic and Atherosclerosis Research Center
Louisville, Kentucky
G. Kees Hovingh, MD
Department of Vascular Medicine
Academic Medical Center
Amsterdam, Netherlands
James A. Underberg, MD
Clinical Assistant Professor of Medicine
NYU School of Medicine
NYU Center for Prevention of Cardiovascular Disease
Director Bellevue Hospital Lipid Clinic
President-Elect National Lipid Association
New York, New York
